1. Wang ZH,
Zhu ZT,
Xiao XY,
et al.
Correlation of serum levels of endostatin with tumor stage in gastric cancer: a systematic review and meta-analysis.
Biomed Res Int 2015,
2015:623939.
2. Dominguez RL,
Crockett SD,
Lund JL,
et al.
Gastric cancer incidence estimation in a resource-limited nation: use of endoscopy registry methodology.
Cancer Causes Control 2013 Feb;24(2):233-9.
3. Sekiguchi M,
Oda I,
Taniguchi H,
et al.
Risk stratification and predictive risk-scoring model for lymph node metastasis in early gastric cancer.
J Gastroenterol 2016 Oct;51(10):961-70.
4. Sasaki T,
Koizumi W,
Higuchi K,
et al.
Therapeutic strategy for type 4 gastric cancer from the clinical oncologist standpoint.
Gan To Kagaku Ryoho 2007 Jul;34(7):988-92.
5. Pan Z,
Pang L,
Ding B,
et al.
Gastric cancer staging with dual energy spectral CT imaging.
PLoS One 2013; 8(2):e53651
6. Tang L,
Li ZY,
Li ZW,
et al.
Evaluating the response of gastric carcinomas to neoadjuvant chemotherapy using iodine concentration on spectral CT: a comparison with pathological regression.
Clin Radiol 2015 Nov;70(11):1198-204.
7. Tang H,
Deng K,
Zhao Y,
et al.
Use of computed tomography gemstone spectral curve in evaluation on histodifferentiation of gastric cancer.
Zhonghua Yi Xue Za Zhi 2014 Dec 9;94(45):3571-4.
Chinese
8. Lv P,
Lin XZ,
Li JY,
et al.
Differentiation of Small Hepatic Hemangioma from Small Hepatocellular Carcinoma: Recently Introduced Spectral CT Method.
Radiology 2011 Jun ;259(3): 720–9.
9. Boll DT,
Patil NA,
Paulson EK,
et al.
Focal Cystic High-Attenuation Lesions: Characterization in Renal Phantom by Using Photon-counting Spectral CT – Improved Differentiation of Lesion Composition.
Radiology Jan; 254(1): 270–6.
10. Lv P,
Lin XZ,
Chen K,
et al.
Spectral CT in patients with small HCC: investigation of image quality and diagnostic accuracy.
Eur Radiol 2012 Oct; 22(10):2117-24.
11. Chang Y,
Niu W,
Lian PL,
et al.
Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.
World J Gastroenterol 2016 Jun 21;22(23):5422-9.
12. Haist T,
Pritzer H,
Pauthner M,
et al.
Prognostic risk factors of early gastric cancer—a western experience.
Langenbecks Arch Surg 2016 Aug;401(5):667-76.
13. Sun YS,
Zhang XY,
Cui Y,
et al.
Spectral CT imaging as a new quantitative tool? Assessment of perfusion defects of pulmonary parenchyma in patients with lung cancer.
Chin J Cancer Res 2013 Dec; 25(6):722-8.
14. Hu S,
Huang W,
Chen Y,
et al.
Spectral CT evaluation of interstitial brachytherapy in pancreatic carcinoma xenografts: preliminary animal experience.
EurRadiol 2014 Sep; 24(9):2167-73.
15. Chen LH,
Xue YJ,
Duan Q,
et al.
Spectral CT imaging in quantitative evaluation on histodifferentiation of gastric cancers.
Chin J Med Imaging Technol 2013 Feb; 29(2):225-9.
Chinese
16. Karim S.
Clinicopathological and p53 gene alteration comparison between young and older patients with gastric cancer.
Asian Pac J Cancer Prev 2014;15(3):1375-9.
17. Wang HM,
Huang CM,
Zheng CH,
et al.
Tumor size as a prognostic factor in patients with advancer gastric cancer in the lower third of the stomach.
World J Gastroenterol 2012 Oct 14; 18(38): 5470-75.
18. Du JR,
Jiang Y,
Zhang YM,
et al.
Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas.
World J Gastroenterol 2003Jul; 9(7):1604-6.
1. Wang ZH,
Zhu ZT,
Xiao XY,
et al.
Correlation of serum levels of endostatin with tumor stage in gastric cancer: a systematic review and meta-analysis.
Biomed Res Int 2015,
2015:623939.
2. Dominguez RL,
Crockett SD,
Lund JL,
et al.
Gastric cancer incidence estimation in a resource-limited nation: use of endoscopy registry methodology.
Cancer Causes Control 2013 Feb;24(2):233-9.
3. Sekiguchi M,
Oda I,
Taniguchi H,
et al.
Risk stratification and predictive risk-scoring model for lymph node metastasis in early gastric cancer.
J Gastroenterol 2016 Oct;51(10):961-70.
4. Sasaki T,
Koizumi W,
Higuchi K,
et al.
Therapeutic strategy for type 4 gastric cancer from the clinical oncologist standpoint.
Gan To Kagaku Ryoho 2007 Jul;34(7):988-92.
5. Pan Z,
Pang L,
Ding B,
et al.
Gastric cancer staging with dual energy spectral CT imaging.
PLoS One 2013; 8(2):e53651
6. Tang L,
Li ZY,
Li ZW,
et al.
Evaluating the response of gastric carcinomas to neoadjuvant chemotherapy using iodine concentration on spectral CT: a comparison with pathological regression.
Clin Radiol 2015 Nov;70(11):1198-204.
7. Tang H,
Deng K,
Zhao Y,
et al.
Use of computed tomography gemstone spectral curve in evaluation on histodifferentiation of gastric cancer.
Zhonghua Yi Xue Za Zhi 2014 Dec 9;94(45):3571-4.
Chinese
8. Lv P,
Lin XZ,
Li JY,
et al.
Differentiation of Small Hepatic Hemangioma from Small Hepatocellular Carcinoma: Recently Introduced Spectral CT Method.
Radiology 2011 Jun ;259(3): 720–9.
9. Boll DT,
Patil NA,
Paulson EK,
et al.
Focal Cystic High-Attenuation Lesions: Characterization in Renal Phantom by Using Photon-counting Spectral CT – Improved Differentiation of Lesion Composition.
Radiology Jan; 254(1): 270–6.
10. Lv P,
Lin XZ,
Chen K,
et al.
Spectral CT in patients with small HCC: investigation of image quality and diagnostic accuracy.
Eur Radiol 2012 Oct; 22(10):2117-24.
11. Chang Y,
Niu W,
Lian PL,
et al.
Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.
World J Gastroenterol 2016 Jun 21;22(23):5422-9.
12. Haist T,
Pritzer H,
Pauthner M,
et al.
Prognostic risk factors of early gastric cancer—a western experience.
Langenbecks Arch Surg 2016 Aug;401(5):667-76.
13. Sun YS,
Zhang XY,
Cui Y,
et al.
Spectral CT imaging as a new quantitative tool? Assessment of perfusion defects of pulmonary parenchyma in patients with lung cancer.
Chin J Cancer Res 2013 Dec; 25(6):722-8.
14. Hu S,
Huang W,
Chen Y,
et al.
Spectral CT evaluation of interstitial brachytherapy in pancreatic carcinoma xenografts: preliminary animal experience.
EurRadiol 2014 Sep; 24(9):2167-73.
15. Chen LH,
Xue YJ,
Duan Q,
et al.
Spectral CT imaging in quantitative evaluation on histodifferentiation of gastric cancers.
Chin J Med Imaging Technol 2013 Feb; 29(2):225-9.
Chinese
16. Karim S.
Clinicopathological and p53 gene alteration comparison between young and older patients with gastric cancer.
Asian Pac J Cancer Prev 2014;15(3):1375-9.
17. Wang HM,
Huang CM,
Zheng CH,
et al.
Tumor size as a prognostic factor in patients with advancer gastric cancer in the lower third of the stomach.
World J Gastroenterol 2012 Oct 14; 18(38): 5470-75.
18. Du JR,
Jiang Y,
Zhang YM,
et al.
Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas.
World J Gastroenterol 2003Jul; 9(7):1604-6.